Adverse Events Module

Adverse Events Module

For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.

Adverse Events Module path is as follows:

Study -> Results Section -> Adverse Events Module -> Event Groups

Study -> Results Section -> Adverse Events Module -> Serious Events

Study -> Results Section -> Adverse Events Module -> Other Events

Adverse Events Module


Ignite Creation Date: 2025-12-24 @ 2:16 PM
Ignite Modification Date: 2025-12-25 @ 12:54 PM
NCT ID: NCT00564395
Description: None
Frequency Threshold: 5
Time Frame: 10 days for each intervention
Study: NCT00564395
Study Brief: Detemir: Role in Type 1 Diabetes
Event Groups(If Any):

Event Groups

Title Description Deaths # Affected Deaths # At Risk Serious # Affected Serious # At Risk Other # Affected Other # At Risk View
Insulin Detemir Mixed With RAI Injection Participants who received Insulin Detemir mixed with RAI, twice daily as subcutaneous injection for 10 days. 0 None 0 14 0 14 View
Insulin Detemir and RAI Injection Separately Participants who received Insulin Detemir and RAI as separate subcutaneous injections, twice daily for 10 days. 0 None 0 14 0 14 View
Serious Events(If Any):
Other Events(If Any):